Hovione honored with the Leonardo da Vinci Prize 2025
Presented by the Hénokiens Association and the Château du Clos Lucé
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Presented by the Hénokiens Association and the Château du Clos Lucé
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Outsourced Pharma, April 2023
Fierce Pharma, 26 March 2026
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.